Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Irene S. Yu"'
Autor:
Emma Titmuss, Irene S. Yu, Erin D. Pleasance, Laura M. Williamson, Karen Mungall, Andrew J. Mungall, Daniel J. Renouf, Richard Moore, Steven J. M. Jones, Marco A. Marra, Janessa J. Laskin, Kerry J. Savage
Publikováno v:
Current Oncology, Vol 31, Iss 4, Pp 1865-1875 (2024)
Immune checkpoint inhibitors (ICIs) are increasingly used in the treatment of many tumor types, and durable responses can be observed in select populations. However, patients may exhibit significant immune-related adverse events (irAEs) that may lead
Externí odkaz:
https://doaj.org/article/165bce1a3d6f4c00a9c7740f49ec203b
Autor:
Angela S. Mathews, Ashley Paul, Irene S. Yu, Colleen McGahan, Eric Bhang, Diego Villa, Karen Gelmon, Antonio Avina-Zubieta, Alina S. Gerrie, Ursula Lee, Stephen Chia, Ryan R. Woods, Jonathan M. Loree
Publikováno v:
Heliyon, Vol 8, Iss 12, Pp e12140- (2022)
Objective: We evaluated survival outcomes for patients with cancer and COVID-19 in this population-based study. Methods: A total of 631 patients who tested positive for severe acute respiratory syndrome coronavirus 2 and were seen at BC Cancer betwee
Externí odkaz:
https://doaj.org/article/8252bc540db744ebbf315444592401bb
Autor:
Irene S. Yu, Francine Aubin, Rachel Goodwin, Jonathan M. Loree, Cheryl Mather, Brandon S. Sheffield, Stephanie Snow, Sharlene Gill
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 14 (2022)
The systemic therapy management of metastatic colorectal cancer (mCRC) has evolved from primarily cytotoxic chemotherapies to now include targeted agents given alone or in combination with chemotherapy, and immune checkpoint inhibitors. A better unde
Externí odkaz:
https://doaj.org/article/5a0a4d000efa47e69955a3b20f714ae4
Autor:
Irene S. Yu, Shiru L. Liu, Valeriya Zaborska, Tyler Raycraft, Sharlene Gill, Howard Lim, Janine M. Davies
Publikováno v:
Current Oncology, Vol 28, Iss 1, Pp 396-404 (2021)
Background: The treatment of hepatocellular carcinoma (HCC) includes different therapeutic modalities and multidisciplinary tumor board reviews. The impact of geography and treatment center type (quaternary vs. non-quaternary) on access to care is un
Externí odkaz:
https://doaj.org/article/42ecc8708a59439b9b894ceb322b7a25
Autor:
Irene S. Yu, Winson Y. Cheung
Publikováno v:
Canadian Journal of Gastroenterology and Hepatology, Vol 2018 (2018)
Colorectal cancer is the second most common malignancy diagnosed in Canada. Despite declining incidence and mortality rates in recent years, there is still a significant number of cases that are metastatic at presentation. Fluoropyrimidine-based chem
Externí odkaz:
https://doaj.org/article/634f9f290c3c48438b7d01b779ab5a3c
Autor:
Irene S. Yu, Winson Y. Cheung
Publikováno v:
Canadian Journal of Gastroenterology and Hepatology, Vol 2018 (2018)
Pancreatic cancer continues to represent one of the leading causes of cancer-related morbidity and mortality in the developed world. Over the past decade, novel systemic therapy combination regimens have contributed to clinically meaningful and stati
Externí odkaz:
https://doaj.org/article/053dd9463cd648c68f1b6b21e40fd750
Autor:
Irene S, Yu, Kathleen, Wee, Laura, Williamson, Emma, Titmuss, Jianghong, An, Sheida, Naderi-Azad, Corey, Metcalf, Stephen, Yip, Basil, Horst, Steven J M, Jones, Katherine, Paton, Brad H, Nelson, Marco, Marra, Janessa J, Laskin, Kerry J, Savage
Publikováno v:
Melanoma Research. 32:278-285
Uveal melanoma is the most common intraocular malignancy and has a poor prognosis compared to other melanoma subtypes with a median overall survival of 6-10 months. With immune checkpoint inhibitor therapy, either PD-1 inhibitor alone or combination
Autor:
Caroline Speers, Jonathan M. Loree, Daniel J. Renouf, Zamzam Al-Hashami, Heather Stuart, Parv Chapani, Howard John Lim, Janine M. Davies, Irene S. Yu, Sharlene Gill
Publikováno v:
Clinical Colorectal Cancer. 21:107-113
Small bowel cancers are rare gastrointestinal malignancies and tumor location impact on outcomes is unclear.A retrospective review was performed on stage I to IV small bowel cancer cases from 2000 to 2017 in British Columbia, Canada. Baseline patient
Autor:
Sharlene Gill, Janine M. Davies, Howard John Lim, Shiru L. Liu, Tyler Raycraft, Irene S. Yu, Valeriya O. Zaborska
Publikováno v:
Current Oncology
Volume 28
Issue 1
Pages 42-404
Current Oncology, Vol 28, Iss 42, Pp 396-404 (2021)
Volume 28
Issue 1
Pages 42-404
Current Oncology, Vol 28, Iss 42, Pp 396-404 (2021)
Background: The treatment of hepatocellular carcinoma (HCC) includes different therapeutic modalities and multidisciplinary tumor board reviews. The impact of geography and treatment center type (quaternary vs. non-quaternary) on access to care is un
Publikováno v:
Clinical Nuclear Medicine. 46:e23-e26
Cardiac metastases are an infrequent site of metastasis in neuroendocrine tumors, and the treatment implications in the era of peptide receptor radionuclide therapy (PRRT) are unclear. Potential safety concerns exist regarding cardiac integrity and f